Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 3.07 1.32% 0.04
SCPH closed up 1.32 percent on Tuesday, April 23, 2019, on 1.72 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Up
See historical SCPH trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Stochastic Reached Overbought Strength 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Resistance Bearish 1.32%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.32%
Calm After Storm Range Contraction 1.32%
Upper Bollinger Band Touch Strength 1.32%
50 DMA Resistance Bearish 0.33%

Older signals for SCPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Medicine Biopharmaceutical Drugs Chemical Compounds Medication Pharmaceutical Products Dosage Forms Heart Failure Chloroarenes Injection Intravenous Therapy
Is SCPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 15.7
52 Week Low 2.44
Average Volume 41,441
200-Day Moving Average 4.2717
50-Day Moving Average 3.0697
20-Day Moving Average 2.8728
10-Day Moving Average 2.81
Average True Range 0.2398
ADX 18.74
+DI 19.5221
-DI 18.0385
Chandelier Exit (Long, 3 ATRs ) 2.6506
Chandelier Exit (Short, 3 ATRs ) 3.1594
Upper Bollinger Band 3.1737
Lower Bollinger Band 2.5719
Percent B (%b) 0.83
BandWidth 20.948204
MACD Line -0.054
MACD Signal Line -0.1035
MACD Histogram 0.0495
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.40
Resistance 3 (R3) 3.41 3.30 3.35
Resistance 2 (R2) 3.30 3.22 3.30 3.33
Resistance 1 (R1) 3.19 3.17 3.14 3.18 3.31
Pivot Point 3.08 3.08 3.06 3.08 3.08
Support 1 (S1) 2.97 3.00 2.92 2.96 2.83
Support 2 (S2) 2.86 2.95 2.86 2.81
Support 3 (S3) 2.75 2.86 2.80
Support 4 (S4) 2.74